Regeneron Pharmaceuticals | REGN - DŁUG





DŁUG Zmiana Data
AbbVie USD 70.82B 2.04B 2026-06
Agenus USD 35.54M 2.34M 2025-03
Agios Pharmaceuticals USD 31.17M 4.57M 2026-06
Alnylam Pharmaceuticals USD 2.48B 1.21B 2026-09
Amgen USD 57.3B 19M 2026-06
Astellas Pharma JPY 589.87B 23.92B 2026-06
AstraZeneca USD 32.24B 1.68B 2026-06
Biogen USD 7.69B 398.3M 2026-09
BioMarin Pharmaceutical USD 4.19B 11.99M 2026-09
Bristol-Myers Squibb USD 42.88B 2.18B 2026-09
Eli Lilly USD 54.91B 11.54B 2026-06
Gilead Sciences USD 26.25B 4.07B 2026-06
GlaxoSmithKline GBP 18.24B 818M 2026-06
Incyte USD 38.27M 1.16M 2026-06
Ionis Pharmaceuticals USD 1.77B 141M 2026-09
J&J USD 49.04B 5.95B 2026-06
Kyowa Hakko Kirin JPY 28.75B 5.04B 2024-12
Merck USD 53.91B 4.79B 2026-06
Moderna USD 1.29B 11M 2026-06
Neurocrine Biosciences USD 392.3M 9.5M 2026-09
Novartis USD 49.01B 2.02B 2026-06
Novartis USD 48.31B 1.31B 2026-09
Pfizer USD 62.67B 523M 2026-09
Puma Biotechnology USD 89.06M 55.07M 2024-06
Regeneron Pharmaceuticals USD 2.71B 400K 2026-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 23.58B 3.56B 2026-06
Sarepta Therapeutics USD 857.36M 188.48M 2026-09
Teva Pharmaceutical Industries USD 16.98B 110M 2026-09
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
United Therapeutics USD 200M 100M 2025-03
Vertex Pharmaceuticals USD 6.48B 4.5B 2026-09